Joining Our Personalized Oncology Investment Cycle Team

Our next investment cycle targets Personalized Oncology: Innovations that tailor cancer care to each patient, including personalized therapies, management, diagnostics, and decision support solutions utilizing AI/ML and advanced analytics. This approach optimizes therapeutic strategies, enhances treatment efficacy, and improves patient outcomes and quality of life.

To be considered for this team, please review and respond to the questions below: